دورية أكاديمية
Cervical cancer screening and prevention among female gynecologic oncologists in Indonesia
| العنوان: | Cervical cancer screening and prevention among female gynecologic oncologists in Indonesia |
|---|---|
| المؤلفون: | Tjokroprawiro, Brahmana Askandar, Indra Yuliati, Laila Nuranna, Tofan Widya Utami, Tricia Dewi Anggraeni, Khoirunnisa Novitasari, Renata Alya Ulhaq |
| المصدر: | Bali Medical Journal; Vol. 12 No. 1 (2023): (Available online : 1 April 2023); 1158-1162 ; 2302-2914 ; 2089-1180 |
| بيانات النشر: | DiscoverSys Inc. |
| سنة النشر: | 2023 |
| المجموعة: | Bali Medical Journal |
| مصطلحات موضوعية: | cervical cancer, female gynecologic oncologist, screening, vaccination |
| الوصف: | Background: Cervical cancer has become a significant health problem in developing countries. We researched cervical cancer screening and prevention among all female gynecologic oncologists (FGO) registered with the Indonesian Society of Gynecologic Oncologists (INASGO). Methods: Participant data and cervical cancer screening and prevention data were collected using an online questionnaire. A total sampling technique was conducted, and 18 of 20 FGOs responded to the survey. All data were analyzed descriptively. Results: Fourteen FGOs (77.8%) had their first cervical screening at the age of 31-40 years old, primarily using Pap smears (77.8%) and Pap-human papillomavirus (HPV) co-testing (22.2%). Half of the included FGOs (50%) had irregular cervical cancer screening due to lack of time (66.7%), followed by forgetting (33.3%). Most FGOs preferred liquid-based cytology (77.8%) over conventional Pap smears (22.2%). Half of the FGOs preferred the HPV genotyping and half the HPV non-genotyping test. Most of the FGOs had screenings performed by female gynecologists (77.8%), male gynecologists (11.1%), and female general practitioners (5.6%). Most FGOs underwent screenings at health facilities outside their workplace (88.9%) and were funded by themselves (94.4%). Most FGOs were vaccinated with the HPV vaccine (77.8%), and most were with the quadrivalent (85.7%) over the bivalent vaccine (14.3%). All respondents were completely (three doses) vaccinated. Conclusion: Most of the FGOs in Indonesia have been vaccinated against HPV and screened for cervical cancer, although half are still not regularly screened. The liquid-based cytology Pap smear and the quadrivalent HPV vaccine are the preferred cervical screening and prevention methods among FGOs in Indonesia |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | English |
| العلاقة: | https://balimedicaljournal.org/index.php/bmj/article/view/3980/2678Test; https://balimedicaljournal.org/index.php/bmj/article/view/3980Test |
| DOI: | 10.15562/bmj.v12i1.3980 |
| الإتاحة: | https://doi.org/10.15562/bmj.v12i1.3980Test https://balimedicaljournal.org/index.php/bmj/article/view/3980Test |
| حقوق: | http://creativecommons.org/licenses/by-nc-nd/4.0Test |
| رقم الانضمام: | edsbas.1A3F3444 |
| قاعدة البيانات: | BASE |
| DOI: | 10.15562/bmj.v12i1.3980 |
|---|